Cardiac-specific CGI-58 deficiency activates the ER stress pathway to promote heart failure in mice

• Published in: Cell death & disease 2021-10, Vol.12 (11), p.1003-1003, Article 1003
• Main Authors: Xie, Xin, Tie, Yi-Fan, Lai, Song, Zhang, Yun-Long, Li, Hui-Hua, Liu, Ying
• Format: Article
• Language: English
• Subjects: 1-Acylglycerol-3-Phosphate O-Acyltransferase - deficiency; 631/443/592/75/230; 692/699/75/230; 82/51; 82/79; 82/80; Amino acids; Animals; Antibodies; Biochemistry; Biomedical and Life Sciences; Cardiomyocytes; Cell Biology; Cell Culture; Congestive heart failure; Echocardiography; Endoplasmic Reticulum Stress - genetics; Fatty acids; Heart failure; Heart Failure - genetics; Heart Failure - mortality; Heart Failure - physiopathology; Immunology; Life Sciences; Male; Metabolism; Mice; Mitochondria; Myocytes, Cardiac - metabolism; Oxidative stress; Proteomics; Steatosis; Structure-function relationships; Survival Analysis; Triglycerides; Western blotting
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-021-04282-7

Excess myocardial triacylglycerol accumulation (i.e., cardiac steatosis) impairs heart function, suggesting that enzymes promoting triacylglycerol metabolism exert essential regulatory effects on heart function. Comparative gene identification 58 (CGI-58) is a key enzyme that promotes the hydrolysis of triglycerides by activating adipose triglyceride lipase and plays a protective role in maintaining heart function. In this study, the effects of CGI-58 on heart function and the underlying mechanism were investigated using cardiac-specific CGI58-knockout mice (CGI-58 cko mice). Echocardiography and pathological staining were performed to detect changes in the structure and function of the heart. Proteomic profiling, immunofluorescent staining, western blotting, and real-time PCR were used to evaluate molecular changes. In CGI-58 cko mice, we detected cardiac hypertrophic remodeling and heart failure associated with excessive cardiac lipid accumulation, ROS production, and decreased expression of regulators of fatty acid metabolism. These changes were markedly attenuated in CGI-58 cko mice injected with rAAV9-CGI58. A quantitative proteomics analysis revealed significant increases in the expression of ER stress-related proteins and decreases in proteins related to fatty acid and amino acid metabolism in the hearts of CGI-58 cko mice. Furthermore, the inhibition of ER stress by the inhibitor 4-PBA improved mitochondrial dysfunction, reduced oxidative stress, and reversed cardiac remodeling and dysfunction in cultured cardiomyocytes or in CGI-58 cko mice. Our results suggested that CGI-58 is essential for the maintenance of heart function by reducing lipid accumulation and ER stress in cardiomyocytes, providing a new therapeutic target for cardiac steatosis and dysfunction.